The Senate overwhelmingly passed the FDA user fee bill, sending it to President Obama, but not before one member delayed proceedings in an apparent protest of the speed in which the bill moved through Congress.
The FDA Safety and Innovation Act, which would reauthorize the prescription drug and medical device user fees, create new programs for generic drugs and biosimilars, and make other FDA policy changes, passed the Senate 92-4 on June 26